Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

We compared serious early and late events experienced by 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors who underwent collection of PBSC or BM between 2004 and 2009 as part of a prospective study through the National Marrow Donor Program. Standardized FDA definitions for ser...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Pulsipher, Michael A., Chitphakdithai, Pintip, Logan, Brent R., Navarro, Willis H., Levine, John E., Miller, John P., Shaw, Bronwen E., O’Donnell, Paul V., Majhail, Navneet S., Confer, Dennis L.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2014
Θέματα:
Transfusion Medicine
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047500/
https://ncbi.nlm.nih.gov/pubmed/24735965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-542464
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια